Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective
Authors:
Open Access
- 27 March 2013
- journal article
- review article
- Published by Taylor & Francis in Biomarkers
- Vol. 18 (3) , 183-195
Abstract
Manufacturers have developed prototype cigarettes yielding reduced levels of some tobacco smoke toxicants, when tested using laboratory machine smoking under standardised conditions. For the scientific assessment of modified risk tobacco products, tests that offer objective, reproducible data, which can be obtained in a much shorter time than the requirements of conventional epidemiology are needed. In this review, we consider whether biomarkers of biological effect related to oxidative stress can be used in this role. Based on published data, urinary 8-oxo-7,8-dihydro-2-deoxyguanosine, thymidine glycol, F-2-isoprostanes, serum dehydroascorbic acid to ascorbic acid ratio and carotenoid concentrations show promise, while 4-hydroxynonenal requires further qualification.Keywords
This publication has 147 references indexed in Scilit:
- DNA damage induced by endogenous aldehydes: Current state of knowledgeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes ApoptosisJournal of Biological Chemistry, 2011
- Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humansFree Radical Biology and Medicine, 2011
- Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation studyFree Radical Biology and Medicine, 2010
- Association of Plasma Micronutrient Levels and Urinary Isoprostane with Risk of Lung Cancer: The Multiethnic Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Validation of Analytic Methods for Biomarkers Used in Drug DevelopmentClinical Cancer Research, 2008
- Pathways connecting inflammation and cancerCurrent Opinion in Genetics & Development, 2008
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- The Hallmarks of CancerCell, 2000